Drug Database
Back to search

United States· US:16252-540_8717ad76-5827-4af3-a808-ee1d98994030

Isradipine

A isradipine product containing isradipine, registered in United States by Teva Pharmaceuticals USA, Inc.. The same ATC class is registered in 5 of our 19 countries.

ATC C08CA03

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedIsradipineATCC08CA03REGISTER NO.US:16252-540_8717ad76…PACKS LISTED1CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about isradipineAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Isradipine is registered in 5 of 19 countries.

Countries holding a registration under ATC C08CA03 (isradipine), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 4 of them publish a price we can compare per daily dose
Search isradipine products by name

Isradipine · ATC C08CA03

5 / 19 countries

  • Belgiumprice
  • Finlandprice
  • Franceprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of isradipine costs, country by country.

Normalised to the WHO defined daily dose (5 mg), so markets compare like for like.

  • United States: $1.99 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Isradipine · price per daily dose (5 mg)

USD · FX 28 Sept 2026

  • US United States$1.99 (acquisition cost)
Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
ISRADIPINE
Manufacturer
Teva Pharmaceuticals USA, Inc.
Country
United States (US)
ATC code
C08CA03
ATC class
Isradipine
Defined daily dose
5 mg, O
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 1

  • ndc11
    16252-540-01

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

283 interactions on record for isradipine.

Graded by severity as the source publishes them — 8 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check isradipine against other medicinesHow interaction checks work

Isradipine · interactions on record

283 records

  • 8 severe
  • 171 moderate
  • 2 minor
  • 55 info

Most severe, free to view

  • DolasetronA04AA04severe
  • CeritinibL01ED02severe
  • CeritinibL01XE28severe
  • MitotaneL01XX23severe

47 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Isradipine in 5 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All isradipine products

Authorised across Europe · EMA

The same active substance is authorised in 1 EEA country. Names it is sold under:

  • France · Icaz Lp

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c1db6985-c1c0-4f1f-9a89-aec99d6d1dae
GET /v1/drugs/c1db6985-c1c0-4f1f-9a89-aec99d6d1dae?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "5",
  "substance": "ISRADIPINE",
  "productndc": "16252-540",
  "dosage_form": "CAPSULE",
  "dea_schedule": null,
  "strength_unit": "mg/1",
  "application_number": "ANDA077317",
  "marketing_category": "ANDA"
}
API referenceMCP serverPlans

See everything about isradipine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console